Constraint-based modeling identifies new putative targets to fight colistin-resistant A. baumannii infections
Abstract Acinetobacter baumannii is a clinical threat to human health, causing major infection outbreaks worldwide. As new drugs against Gram-negative bacteria do not seem to be forthcoming, and due to the microbial capability of acquiring multi-resistance, there is an urgent need for novel therapeu...
Guardado en:
Autores principales: | Luana Presta, Emanuele Bosi, Leila Mansouri, Lenie Dijkshoorn, Renato Fani, Marco Fondi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ad8bd12afc6c4b0f8a8764e490f98663 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diversity in the major polysaccharide antigen of Acinetobacter baumannii assessed by DNA sequencing, and development of a molecular serotyping scheme.
por: Dalong Hu, et al.
Publicado: (2013) -
Effects of colistin and tigecycline on multidrug-resistant Acinetobacter baumannii biofilms: advantages and disadvantages of their combination
por: Yoshinori Sato, et al.
Publicado: (2021) -
Colistin Resistance Onset Strategies and Genomic Mosaicism in Clinical <i>Acinetobacter baumannii</i> Lineages
por: Viviana Cafiso, et al.
Publicado: (2021) -
Prospective observational study of the impact of plasma colistin levels in patients with carbapenem-resistant Acinetobacter baumannii pneumonia
por: Yun-Jeong Jeong, et al.
Publicado: (2021) -
¿Se debe revisar la determinación de la CIM de colistín en Acinetobacter baumannii?
por: Villanueva,Xabier, et al.
Publicado: (2017)